Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Adams Reiterates a 'Hold' on Allos Therapeutics (ALTH); Survey Provides Glimpse Into Folotyn Awareness
-
Canaccord Adams Reiterates a 'Hold' on IRIS International (IRIS); 2011 Story is Taking Shape
-
Canaccord Adams Reiterates a 'Hold' on Hologic (HOLX); FQ2 Mix Shift Weighs on EPS
-
Canaccord Adams Reiterates a 'Buy' on HeartWare International (HTWR); Q1 Results Above Expectations, All Eyes On The Future
-
Canaccord Adams Maintains a 'Buy' on Cutera (CUTR), Q1/10 Exhibits Domestic Weakness But Outlook Positive
-
Canaccord Adams Maintains a 'Hold' on Answers (ANSW); Traffic & RPM Decelerating Into Q2; Staying Cautious Until Initiatives Show Improvement
-
Canaccord Adams Maintains a 'Buy' Goldcorp (GG); Announces the Sale of the Escobal Project
-
Canaccord Adams Reiterates a 'Buy' on Whiting Petroleum (WLL), Raising Target on Solid Quarter
-
Canaccord Adams Reiterates a 'Buy' on T-3 Energy Services (TTES); Good Q1 Results, Backlog Turns the Corner
-
Canaccord Adams Reiterates a 'Buy' on Brigham Exploration (BEXP); Q1 Beat and Operational Update
-
Wall Street Giddy About Dendreon (DNDN) After Provenge Approval; Where Are Shares Headed?
-
Canaccord Adams Reiterates a 'Buy' on Motorola (MOT); Smartphone Strategies Yields Results
-
Canaccord Adams Reiterates a 'Buy' on EnerNOC (ENOC); Q1/10 preview
-
Canaccord Adams Reiterates a 'Buy' on Rubicon Technology (RBCN); Superboule Champions!
-
Canaccord Adams Reiterates a 'Buy' on Thoratec (THOR); Adding to Positions
-
Canaccord Adams Maintains a 'Buy' on Greatbatch (GB); Attractive Valuation
-
Canaccord Adams Reiterates a 'Buy' on Dendreon (DNDN); Raises PT on Provenge FDA Approval
-
Canaccord Adams Reiterates a 'Buy' on Maxim Integrated Products (MXIM); Demand Continues to Outstrip Supply
-
Canaccord Adams Reiterates a 'Buy' on Constant Contact (CTCT); Strong Q1/10 Upside Leaves FY Heading Higher
-
Canaccord Adams Upgrades Dolby Laboratories (DLB) to Buy; Strong Q1 beat; Raises 2010 Guidance on Accelerating Broadcast
-
Canaccord Adams Reiterates a 'Buy' on Noble Energy (NBL); Another Good Quarter
-
Canaccord Adams Maintains a 'Buy' Rating on Oil States International (OIS); Raises PT
-
Canaccord Adams Reiterates a 'Buy' on Key Energy Services (KEG); Margins Disappoint But Due to Recover
-
Canaccord Adams Reinstates a 'Hold' Rating on Cenovus Energy (CVE); Revised Estimates & PT After Q1 Results
-
Canaccord Adams Comments on Metals and Mining -- Agriculture Stocks
-
Canaccord Adams Downgrades Axitron AG (AIXG) to Hold
-
Canaccord Adams maintains a 'Hold' on First Solar (FSLR); Leveraging Mix and Tight Macro, But Project Development Pressure Persists
-
Canaccord Adams Reiterates a 'Buy' on Green Mountain Coffee (GMCR); Margin Power Gets Hidden & Under-Appreciated
-
Canaccord Adams Reiterates a 'Buy' Rating on Life Sciences Stocks - ILMN, IMA & OFIX
-
Canaccord Adams Reiterates a 'Buy' on RightNow Technologies (RNOW); Solid Bookings Leave Outlook Positive Despite Foreign Exchange Dampener
-
Canaccord Adams Reiterates a 'Buy' on LogMeIn (LOGM); Third "At Risk" Quarter Strong; Solid Track Record Growing
-
Canaccord Adams Reiterates a 'Buy' on Epicor Software (EPIC); Solid Q1/10 After Strong Q4/09 Leaves Momentum Intact
-
Canaccord Adams Reiterates a 'Buy' on Xilinx (XLNX); Raises PT & Estimates
-
Canaccord Adams Maintains a 'Buy' on Internet Brands (INET); Better Guidance on Accelerating Audience Growth
-
Canaccord Adams Maintains a 'Buy' Rating on RPC, Inc. (RES); Raises PT on Blow Out Qtrly Results
-
Canaccord Adams Maintains a 'Buy/Best Idea' on Metalico (MEA); Buy Ahead of Q1 Earnings Report
-
Canaccord Adams Reiterates a 'Buy' on Volcano Corp (VOLC), Attractive Small-Cap Med-Tech Acquisition Candidate
-
Canaccord Adams Reiterates a 'Buy' on Seattle Genetics (SGEN); Don't Read Too Much Into Lintuzumab Phase II Delay
-
Canaccord Adams Reiterates a 'Buy' on AMAG Pharmaceuticals (AMAG); Disappointing Q1 Sales Mask Positive Demand Trends
-
Canaccord Adams Reiterates a 'Buy' on Ultimate Software (Nasdaq: ULTI); Beginning Year on a Positive Note
-
Canaccord Adams Reiterates a 'Buy' on National Oilwell Varco (NOV); Q1 Results iimpress, But Rig Tenders Delayed
-
RIM's (RIMM) New BlackBerry OS Impresses Some, Others Say Company Still Playing Catch Up
-
Canaccord Adams Reiterates a 'Buy' on Itron (ITRI); Playing Offense with OpenWay
-
Canaccord Adams Reiterates a 'Buy' on Alphatec (ATEC); Hosts Technology Day; Strong Differentiated Pipeline Should Reaccelerate Growth
-
Canaccord Adams Reiterates a 'Hold' on Zoran Corporation (ZRAN); Pricing Pressure/Inventory Adjustment Hamper Results
-
Canaccord Adams Reiterates a 'Buy' on Advanced Analogic Technologies (AATI); Uncertain Handset Trends Offset By TV Pipeline
-
Canaccord Adams Reiterates a 'Buy' on Volterra Semiconductor (VLTR); Strong Results & Guidance with Product Cycles Extending Visibility Into 2011
-
Canaccord Adams Reiterates a 'Buy' on Texas Instruments (TXN); Analog Products Drive Upside; 300mm Fab Poised to Drive Down Costs
-
Canaccord Adams Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA)
-
Canaccord Adams Reiterates a 'Buy' on Schlumberger (SLB); Q1 Results In Line; Bright Outlook Takes Spotlight

